Biolabssss

overview of sdAb library screening

Tumors are not merely masses of malignant cells, but complex ecosystems composed of different types of cells. Among these cells, tumor infiltrated immune cells play a central role in tumor control and response to therapy. Characterization of every tumor infiltrated immune cell at single-cell level in pre- and on-treatment tumor samples holds promise to identify novel biomarkers for the monitoring and prediction of response. With unrivaled expertise in single-cell analysis, Single Cell offers superior quality single-cell omics solutions for tumor infiltrated immune cells.

Single cell immune profiling is a critical approach to study immune repertoires of thousands of immune cells, elucidate the key anti-virus adaptive immune responses, and explore potential immunomodulatory therapeutic strategies. As a flexible partner in the single cell multiomics services, Creative Biolabs aspires to provide the most comprehensive immune profiling services, including but not limited to analyses of cellular context, diversity, antigen specificity, immune cell subpopulations, BCR/TCR sequences, and TCR-MHC specificity. We are committed to advancing your immune profiling program

Creative Biolabs has an entrepreneurial team of highly-skilled and qualified experts in hapten design and synthesis. The members have originated from a rich academic research background, bringing their experience into translation. We are very proud of providing high-quality, omnidirectional hapten discovery services targeting 3-Amino-2-oxazolidinone (AOZ) for our valued clients to remove the difficulties of your projects. Up to now, we have also generated a novel platform to design, synthesize, evaluate, and modify potential haptens for AOZ. This platform has been considered as an attractive

Creative Biolabs’ professional teams offer the design and synthesis of class-specific haptens for BZs. Moreover, the service also includes the modification and characterization of haptens for BZs based on customers’ special requirements.

Creative Biolabs provides high quality transcription-activator-like effector nuclease. Please contact us if you need more information.

Creative Biolabs provides high quality transcription-activator-like effector nuclease. Please contact us if you need more information.

Innovative and diversified technique platforms to help create modulized delivery systems against a variety of targets.

Creative Biolabs, headquartered in New York, is a leading custom service provider in the field of vaccine development, preclinical assessment and GMP manufacturing. Our technical and regulatory experts can provide vaccine developers with a full range of products and vaccine related services. We combine traditional and the most updated genetic engineering technologies to efficiently produce highly immunogenic and safe vaccines to address emergency unmet medical needs.

Our cutting-edge Native™ Antibody discovery, Hyperdoma™ and Phage Display platforms allow the production of the most comprehensive list of virology recombinant antibody products. Our antibody products range from research use only antibody, diagnostic antibody to therapeutic antibody. We also provide professional custom antibody discovery, engineering and manufacturing services, including featured phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, sdAb, minibody etc.), antibody labeling, hybridoma/s

Our cutting-edge Native™ Antibody discovery, Hyperdoma™ and Phage Display platforms allow the production of the most comprehensive list of virology recombinant antibody products. Our antibody products range from research use only antibody, diagnostic antibody to therapeutic antibody. We also provide professional custom antibody discovery, engineering and manufacturing services, including featured phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, sdAb, minibody etc.), antibody labeling, hybridoma/s